Table 2.
Co-infection, viral load and CD4+ at baseline, 6 months, and at one year of study
| Control Group | Intervention Group | P value a | |||||
|---|---|---|---|---|---|---|---|
| N=51 | N=51 | ||||||
| Basal | 6 months | 1 year | Basal | 6 months | 1 year | ||
| % (n) | % (n) | % (n) | % (n) | % (n) | % (n) | ||
| Absence of co-infection | / | 72.6 (37) | 56.9 (29) | / | 76.5 (39) | 64.7 (33) | 0.092 |
| Viral load <50 copies/ml | 60.8 (31) | 76.5 (39) | 68.6 (35) | 64.8 (33) | 58.8 (30) | 74.5 (38) | 0.869 |
| CD4+>200 cells/mm 3 | 56.9 (29) | 68.6 (35) | 74.5 (38) | 54.9 (28) | 70.8 (34) | 78.4 (40) | 0.793 |
| CD4+>350 cells/mm 3 | 31.4 (16) | 37.3 (19) | 49.0 (25) | 33.3 (17) | 37.5 (18) | 51.0 (26) | 0.977 |
| CD4+>500 cells/mm 3 | 15.7 (8) | 17.7 (9) | 19.6 (10) | 17.7 (9) | 20.8 (10) | 27.5 (14) | 0.599 |
Note: aStatistical significance value - Generalized estimating equations (GEE) test.
Abbreviation: CD4+, lymphocyte T CD4+.